asthma Flashcards

1
Q

what is asthma?

A

An inflammatory disease of the airways characterized by:

Recurrent reversible airways obstruction in response to irritant stimuli
Hypersecretion of mucus by bronchial epithelial cells
Eosinophil infiltration
Bronchial smooth muscle cells hyperplasia causing airway hyper-responsiveness and bronchospasm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

whats the difference in structure between a healthy airway, with asthma and asthma attack?

A

Asthma: smooth muscle cells increased in airway

asthma attack: constricted airway, contracted smooth muscle cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Hyperplasia of goblet cells

A

glandularsimple columnarepithelialcellswhose function is to secretemucin,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is hyperplasia?

A

increase in the number of cells in an organ or tissue.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is hypertrophy?

A

Hypertrophy =increase in size of of smooth muscle suspected to contribute to the irreversible airflow obstruction and permanently impaired pulmonary function observed in patients with chronic asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is airway hyper responsiveness?

A

Airway hyperresponsiveness is a characteristic feature of asthma and consists of an increased sensitivity (abnormal sensitivity) of the airways to chemicals, cold air, stimulant drug e.g., an inhaled constrictor agonist, a steeper slope of the dose-response curve, and a greater maximal response to the agonist. Certain inhaled stimuli, such as environmental allergens, increase airway inflammation and enhance airway hyperresponsiveness.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is bronchospasm?

A

Bronchospasmis an abnormal contraction of the smooth muscle of the bronchi, resulting in an acute narrowing and obstruction of the respiratoryairway.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are the causes of asthma? (pathogenies)

A

Factors increasing chances to develop the condition: identified!

A family history of asthma /allergic conditions
Bronchiolitis as a child
Exposure to tobacco smoke
Being born prematurely
Type of job- occupational exposures
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are the triggers of asthma?

A
Triggers: 
Indoor environment
House dust mites 
Moulds & fungi
Pollen
Food
drugs
Stress or even a fit of laughter
cold and viral infection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is intrinsic asthma?

A

Intrinsic asthma/Or Not obvious allergic bases: : historical definition: asthma caused by substances from “within the body.” These patients usually have a negative allergy skin test, and therefore do not have allergies and do not benefit from allergy shots or allergy medications
intrinsic asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is extrinsic asthma?

A

Extrinsic asthma/Allergic bases: historical definition asthma caused by inhaling or ingesting foreign substances (later known as allergens) from “without the body.” Some causes were in the air, such as horse hair, plant pollens, and feather dust, and some were in the foods ingested, such as eggs, berries, fish and cereals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are the symptoms of asthma?

A
Wheeze
Breathlessness
Cough (occasionally) 
Daily or seasonal variation
Chest tightness
Any triggers that make symptoms worse?
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are objective tests for asthma ?

A

Airway inflammation measurement
Lung function tests
Airway hyperreactivity measurement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

how does Airway inflammationmeasurement work?

A

Measure Fractional exhaled Nitric Oxide in the breath (FeNO).

normal epithelial cell release minimal NO
during imflammation , activated epithelial cell increase production of NO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Where is the NO coming from?

A

In inflammatory diseases, such as asthma, the increase in exhaled NO may reflect, at least in part, induction of NOS2.
In adult asthmatic patients there is evidence of increased expression of NOS2 in airway epithelial cells
Pro-inflammatory cytokines, which may at times be involved in asthmatic inflammation, induce the expression of NOS
Patients with asthma caused by allergic airway inflammation have high levels of FeNO that decrease with corticosteroid treatment
Knowing whether airway inflammation is present can help avoid an empiric trial of steroids

Positive test:
FeNO level of 40parts per billion (ppb) or more(adult)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is the lung function test?

Obstructive spirometry

A

Measure lung volumes and capacity to determine the presence of an obstructive or a restrictive diseases. FEV1 and FVC changes will differe depending on the type of diseases.

Obstructive spirometry
Forced Expiratory Volume 1 sec= volume of air exhaled during the first second of the FVC
Forced Vital Capacity= maximal amount of air that can be exhaled after a maximal breath

Positive test for obstructive airway disease: FEV1/FVC <70% or below the lower limit of normal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q
what is lung function test?
Bronchodilator reversibility (BDR) test
A

Bronchodilator reversibility (BDR) test

Spirometry after inhaling short-acting b2AR agonist

Positive test for reversibility:
an improvement in FEV1 of 12% or more, AND with an increase in volume of 200ml or more

Rationale for this test:
Determine the presence of a reversible airways obstruction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what is lung function test?

peak flow variability?

A

Rationale for this test:
Determine the presence of daily variability of air peak flow.

Peak flow variability
Monitor peak flow variability for 2to 4weeks

If the difference between the highest and lowest values divided by their mean exceeds 20% (and is at least 60 l/min) the diagnosis of asthma is strongly supported.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

explain the airway hyperreactivity measures?

A

Direct bronchial challenge test- with histamine or methacholine

Rationale:

Airway hyperresponsiveness is a characteristic feature of asthma and consists of an increased sensitivity (abnormal sensitivity) of the airways to chemicals, cold air, stimulant drug
In this test, bronchospasm is deliberately induced by controlled and measurable exposure to a specific stimulant. The direct tests aim to detect and quantify airway hypersensitivity: inhaled aerosols of histamine and methacholine act directly on receptors on the bronchial smooth muscle to cause contraction. Results are most often presented as dose-response curves that may be used as an index of the patient’s sensitivity to the stimulant in question
Asthmatics usually demonstrate an excessive response to an inhaled dose of methacholine or histamine which causes little or no change in lung function in normal healthy individuals.

20
Q

Chronic Asthma: Non Pharmacological Management

primary preventions

A

Multifaceted approach to avoid indoor asthma
Aeroallergen and food avoidance
Weight-loss interventions for overweight and obese adults and children with asthma
Microbial exposure and ‘hygiene hypothesis’
Avoid Smoking and air pollution

21
Q

Chronic Asthma: Non Pharmacological Management

secondary preventions

A

House dust mite avoidance: should not be routinely recommended

Breathing exercise programmes (as adjuvant to pharmacological treatment) can be offered to adult to improve quality of life and reduce symptoms.

Family therapy with pharmacotherapy

22
Q

Asthma Management: Pharmacological Treatment

Relievers

A

Relievers
What: Bronchodilators
Inhaled short-acting fast onset β2 adrenoceptor agonists
Inhaled long-acting fast onset β2 adrenoceptor agonists as MART ONLY

Why: Fast control of symptoms given the fast onset of action ≤ 7 min

When: to relieve asthma symptoms and for asthmatic patient with infrequent, short-lived wheeze and normal lung function

23
Q

Asthma Management: Pharmacological Treatment

controller/preventer

A

Controllers/Preventers

What: Long-acting bronchodilators and anti-inflammatory drugs
Inhaled long-acting β2 adrenoceptor agonists (in combination with ICS)
Inhaled and systemic corticosteroids
Leukotriene receptor antagonists
Long-acting muscarinic receptor antagonists
Theophylline

Why: control symptoms and reduce inflammation

When: Regular maintenance therapy to improve symptoms, lung function and prevent asthma attack.

24
Q

Chronic Asthma : Pharmacological Management

according to nice guidelines

A

SABA
SABA + ICS
SABA + ICS + LABA
* check this

25
Q

what is b2 Adrenoceptor Agonists mechanism?

A

Mechanism of action

Activate b2AR in airway smooth muscle
Cause airway smooth muscle relaxation by cAMP-dependent (and independent!) mechanism(s)

26
Q

what is the mechanism of action of salbutamol ?

use

A

Salbutamol
Hydrophilic, it enters the binding site of b2AR, fast onset BUT short action (~3-6 hours)
(Terbutaline)

Use:
Occasional reliever
For acute asthma attacks

Monitor and repeat treatment if needed
Inhaled but also oral, s.c., slow i.v.

27
Q

what is the mechanism of action for salmeterol?

A

Long-acting b2 adrenoceptor agonists

Salmeterol
Long, lipophilic side chain binds to exosite: active portion of the molecule remains at the receptor site
Slow on-set but longer duration of action (~12 hours

28
Q

what are the lung function tests?

A

obstructive spirometry
bronchodilator reversibility
peak flow variability

29
Q

what is the mechanism of action of fometerol?

A

Formoterol

Long-acting b2 adrenoceptor agonists

Moderately lipophilic, taken into depot at cell membrane
Fast onset

30
Q

name some b2-adrenergic agonists and their mechanism?

A
  • salbutamol - Hydrophilic, short action, fast onset
    -formeterol - intermediate, long action, fast onset
    salmeterol - lipophilic, short action, fast onset
31
Q

what is the use of long acting b2 adrenoreceptor agonist?

A
Use:
 Inhaled
 Chronic asthma
 Maintenance And Reliever Therapy- Formoterol 
     Only in combination with ICS
32
Q

what is the advantage and disadvantage of long acting b2 adrenoreceptor agonist?

A

Advantages:
Allow reduction of corticosteroid dose
Reduction of symptoms and improvement of lung function

Disadvantages:
Risk increase of asthma exacerbation, hospitalization, death

33
Q

b2 adrenoceptor agonists- what are the adverse effects

A
Adverse effects:
 Arrythmias, angina precipitation, palpitation, tachycardia 
 Peripheral vasodilation
 Headache 
 Tremor (route/dose-related)

Increased mortality/morbidity (LABA)

34
Q

what are the contradictions of b2 adrenoreceptor agonist?

A

Contraindications and use with caution:
Cardiovascular diseases
Pregnancy

35
Q

what interactions can b2 adrenoreceptor agonist have on other drugs?

A

Interactions with other drugs

Hypokalaemia

36
Q

what is corticosteriod?

A

Most effective anti-inflammatory therapy for asthma

37
Q

what is the mechanism of action of corticosteriod - trans-repression and trans-activation

A
TRANS-REPRESSION
Switch off multiple activated inflammatory genes
and decrease transcription of:
Cytokines (IL1, TNFa)
Chemokines (IL8)
Inflammatory enzymes (COX2, iNOS)
Inflammatory receptors
Others
TRANS-ACTIVATION
Activate anti-inflammatory gene expression
and increase transcription of:
b2-Adrenergic receptor
IL-1 receptor antagonist
Others
38
Q

what can corticosteroids do?

A
  • eosinophil numbers decrease
  • cytokines decrease
  • mast cells decrease
  • macrophages decrease
  • dendritic cells decrease

endotheial cell leak
airway smooth muscle - b2 receptor increase
mucus secretion decrease

39
Q

what are examples of inhaled, oral and parental cortiscosteriod?
and its use?

A
Inhaled:
Beclometasone dipropionate
Budesonide
Fluticasone propionate
Use: recommended preventer drug for adults and children for achieving overall treatment goals

Oral:
Prednisolone
Use: acute and severe asthma

Parenteral:
Hydrocortisone (i.v.)
Use: life-threatening acute asthma

40
Q

what are the side effects of corticosteriod?

A

esp. long term use

Reduction of bone mineral density, osteoporosis
Hypertension
Cataracts and glaucoma
Hyperglycaemia, diabetes
Weight gain
Increased vulnerability to infection
Lower respiratory tract infections
Thinning of the skin and easy bruising
Hoarseness, dysphonia, throat irritation, and candidiasis
Local deposition of inhaled glucocorticoid in the oropharynx and larynx!

41
Q

Pathobiology of asthma: bronchial hyper-reactivity, bronchial spasm and inflammation of the airways

A
immediate phase of asthma attack:
trigger: pollen, airpollutant 
release of mast cell spasomogen - histamine , ltc4 , ltd4 
release of chemotoxins (cytokines)
causes bronchospasm 

delayed phase of asthma attack

  • chemotoxins
  • causes influx / activation of imflammatory cells (eosinophil, monocytes, T cells) which release leukotrine, eosinophil protein
  • which causes bronchospasm- wheezing and coughing
  • increase in hyper reactivity and imflammation
  • which causes mucus
42
Q

Leukotriene Receptor Antagonists(LTRA)

mechanism of action and use

A

Mechanism of action:
Block cysteinyl-leukotrienes receptors on bronchial tissue (and other cells) to reduce bronchoconstriction, mucus secretion, edema, eosinophil migration.

Montelukast
Zafirlukast

Use: Oral asthma preventer NOT as reliever/rescue remedy!

  • increased mucus secretion
  • bronchoconstriction
  • easoniphil and chemotaxin activation
43
Q

Anticholinergic agents
mechanism of action and use
example

A

Mechanism of action:
Antagonist of muscarinic acetylcholine receptors.
-Blockage of M3receptors reduces bronchoconstriction (promoting relaxation of pulmonary smooth muscle and bronchodilation) and reduces mucus secretion

Tiotropium Bromide: long-acting muscarinic antagonist(LAMA)

Use: Recently approved for maintenancetreatment of asthma
In combinations with ICS and LABA
Bigger role in the management of COPD

44
Q

Theophylline

mechanism of action

A

Mechanism of action:
Non-selective phosphodiesterase inhibtor (=↑cAMP)
Non-selective antagonist at adenosine receptors
Activates histone deacetylases (HDACs)
Others unknown

Induces relaxation of the smooth muscle of bronchial airways reducing airways obstruction and airway reponsiveness
inhibits release of inflammatory mediators

45
Q

use of theophylline

A

Use:
oral or parenteral, for chronic and acute asthma

NOTE:
Very small therapeutic window…
Extensively metabolized by liver…
Serum levels must be monitored to avoid toxicity!

46
Q

Severe Persistent Allergic Asthma: Anti-IgE

mechanism of action and use

A

Mechanism of action
Antibody binds to circulating IgE decreasing binding of IgE to the high-affinity IgE receptor (FceRI) in mast cells.

Omalizumab

Use: Subcutaneous injections every 4 weeks, severe persistent IgE-mediated asthma

NOTE effect is not immediately apparent: 12 weeks treatment required!

IgE for antigen connect to the mast cell causes histamine, tryptase, leukotrienes and prostaglandins which causes the asthma symptoms (allergic inflammation)
omalizumb can attach to the IgE antigen and prevent this.

47
Q

Acute Asthma Management:
Pharmacological Treatment in Adults

generic - SIGN guidelines

A
Supplementary oxygen
High-dose inhaled β2 agonists  - Nebuliser / Intravenous
Steroids- Oral/ Parenteral
Nebulised ipratropium bromide 
I.V. aminophylline